Waterbury : Chase Medical Research, LLC
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E4 Non-Carriers.
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research
The Testosterone Trial - Can testosterone treatment improve unwanted effects of aging in older men?
Portland : Summit Research Network (Oregon), Inc.
Dealing with Alzheimer's can leave you wondering which way to turn
